Keyphrases
Adverse Outcomes
100%
Confidence Interval
100%
Adjusted Odds Ratio
100%
National Cohort
100%
Cardiovascular Medications
100%
Match Analysis
100%
Patients with COVID-19
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
85%
Angiotensin Receptor Blockers
85%
Statins
71%
Anticoagulants
57%
Decreased Risk
57%
Mechanical Ventilation
42%
Hospitalization Risk
42%
Intensive Care Unit
28%
Interaction Effect
28%
Intensive Care Unit Admission
28%
COVID-19 Diagnosis
28%
COVID-19 Hospitalization
28%
Hospitalization
14%
Clinical Factors
14%
Clinically Significant
14%
Medication Use
14%
Potential Treatments
14%
COVID-19
14%
Statin Use
14%
Anticoagulant Use
14%
Optum
14%
Ventilator Use
14%
COVID-19 Patients
14%
COVID-19 Data
14%
Nursing and Health Professions
Adverse Outcome
100%
COVID-19
100%
Odds Ratio
77%
Confidence Interval
77%
Angiotensin Receptor Antagonist
66%
Dipeptidyl Carboxypeptidase Inhibitor
66%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
55%
Anticoagulant Agent
55%
Intensive Care Unit
44%
Artificial Respiration
33%
Case-Control Study
11%
Statin (Protein)
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Angiotensin Receptor Antagonist
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
83%
Anticoagulant Agent
83%
Case-Control Study
16%
Statin (Protein)
16%
Neuroscience
Angiotensin Receptor
100%
Statin
100%
ACE Inhibitor
100%
Mechanical Ventilation
50%
Antithrombotic
16%
Anticoagulant
16%